Key learnings from Institute for Clinical and Economic Review’s real-world evidence reassessment pilot
| Autor: | Ashley Jaksa, Lisa Bloudek, Josh J. Carlson, Kanya Shah, Yilin Chen, Amanda R. Patrick, Avery McKenna, Jon D. Campbell |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | International Journal of Technology Assessment in Health Care. 38 |
| ISSN: | 1471-6348 0266-4623 |
| DOI: | 10.1017/s0266462322000162 |
| Popis: | Health technology assessment (HTA) agencies are considering adopting a lifecycle approach to assessments to address uncertainties in the evidence base at launch and to revisit the clinical and economic value of therapies in a dynamic clinical landscape. For reassessments of therapies post launch, HTA agencies are looking to real-world evidence (RWE) to enhance the clinical and economic evidence base, though challenges and concerns in using RWE in decision-making exists. Stakeholders are embarking on demonstration projects to address the challenges and concerns and to further define when and how RWE can be used in HTA decision making. The Institute for Clinical and Economic Review piloted a 24-month observational RWE reassessment. Key learnings from this pilot include identifying the benefits and challenges with using RWE in reassessments and considerations on prioritizing and selecting topics relevant for RWE updates. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|